IPCA Laboratories · NSE: IPCALAB · BSE: 524494
Q4 FY19 results · Jan–Mar 2019
IPCA Laboratories reported revenue from operations of ₹0.00 crore and net profit of ₹0.00 crore for Q4 FY19 (Jan–Mar 2019), on a consolidated basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 0.00 | — | — | — | — |
| Other income | 0.00 | — | — | — | — |
| Total income | 0.00 | — | — | — | — |
| Profit before tax | 0.00 | — | — | — | — |
| Net profit for the period | 0.00 | — | — | — | — |
| EPS, basic (₹) | 0.00 | — | — | — | — |
| Net margin (%) | — | — | — |
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 833.81 | — | — | 947.59 | −12.0% |
| Other income | 14.58 | — | — | 12.63 | +15.4% |
| Total income | 848.39 | — | — | 960.22 | −11.6% |
| Profit before tax | 141.39 | — | — | 196.78 | −28.1% |
| Net profit for the period | 109.47 | — | — | 160.18 | −31.7% |
| EPS, basic (₹) | 8.67 | — | — | 12.68 | −31.6% |
| Net margin (%) | 13.1 | — | 16.9 |
Consolidated
- Filed with BSE
- 30 May 2019, 12:12 IST
- Board meeting
- 29 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 May 2019, 12:11 IST
- Board meeting
- 29 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE